The effect of subclinic thyroid pathologies on erythropoietine dose in hemodialysis patients.
Engin OnanMehmet YasarBusra SoysalSaime PaydasPublished in: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy (2022)
The EPO dose required to achieve similar hemoglobin levels in hemodialysis patients was significantly higher in subclinical hypothyroid patients than in euthyroid patients.